COMMUNIQUÉS West-GlobeNewswire

Mustang Bio to Present at the World Orphan Drug Congress USA 2019
09/04/2019
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Align Technology Completes Purchase of Raleigh Office Building
09/04/2019
Affirms commitment to continued innovation and regional growth with $58 million investment SAN JOSE, Calif., April 09, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN), makers of the Invisalign® system, [...]
Harvest One Ensures Cannabis Supply with Greenbelt Acquisition-- CFN Media
09/04/2019
SEATTLE, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Innovation Pharmaceuticals Reports Enhancements in Manufacture of Brilacidin Phase 3 Drug Supply
09/04/2019
BEVERLY, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has implemented yield and [...]
The Most Prevalent Cannabis E-commerce Platforms in Canada
09/04/2019
VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) -- Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures. However, [...]
TRHC Commends White House Report on Need for Innovative Technology Solutions to Improve Lives of Elderly and Disabled
09/04/2019
MOORESTOWN, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a leading provider of technology-enabled solutions to mitigate medication risk, commends a recent report issued [...]
Allscripts to release first-quarter 2019 financial results May 2
09/04/2019
CHICAGO, April 09, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2019, after the close of stock market hours on [...]
Inspire Medical Systems, Inc. to Report First Quarter 2019 Financial Results on May 7, 2019
09/04/2019
MINNEAPOLIS, April 09, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer
09/04/2019
– Dr. Busch will lead Cyclerion’s Innovation Center and provide strategic oversight of the company’s soluble guanylate cyclase (sGC) portfolio – CAMBRIDGE, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- Cyclerion [...]
Intra-Cellular Therapies Announces Presentation of Lumateperone Long-term Open Label Safety Study at the 2019 Congress of the Schizophrenia International Research Society
09/04/2019
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
09/04/2019
Data will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—positively impact patients with bloodstream infections LEXINGTON, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- [...]
Inhibikase Therapeutics Announces Appointment of Elizabeth O’Farrell to its Board of Directors
09/04/2019
ATLANTA and BOSTON, April 09, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
09/04/2019
Expands use of PhaseBio ELP biopolymer platform designed to support more convenient dosing of proteins and peptides MALVERN, Pa. and SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: [...]
Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil’s Health Regulatory Agency
09/04/2019
MEDFORD, N.Y., April 09, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the approval of its DPP Zika/Dengue [...]
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
09/04/2019
Poster presentation to highlight data from three previously-conducted clinical studies of Sci-B-Vac®, VBI’s prophylactic Hepatitis B vaccine In all three studies, seroprotection rates of more than 98% were achieved [...]
Cerner Announces Agreement with Starboard Value Regarding Board Refreshment, Operational Improvement Initiatives and Expanded Capital Return Program to Drive Next Phase of Profitable Growth and Value Creation
09/04/2019
Four New Directors to Be Immediately Appointed to the Board of Directors Commitment to Adjusted Operating Margin Targets for Q4 2019 and Q4 2020 of 20% and 22.5%, Respectively 1 Creation of Finance and Strategy [...]
Frank J. Quintero Joins BioSig Technologies Advisory Board
09/04/2019
Santa Monica, CA, April 09, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Tauriga Sciences, Inc. to Develop Airport Version of its CBD Infused Chewing Gum
09/04/2019
NEW YORK, NY, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
09/04/2019
LOS ANGELES, April 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a global healthcare awareness initiative with United Smart Cities for [...]

Pages